BWLSA
AMRS

Blue Water Life Science Advisors’s Amyris Inc. AMRS Stock Holding History

Blue Water Life Science Advisors’s Portfolio AMRS Stock Details AMRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,217,216
Closed -$36.3M – 26
2021
Q2 		$36.3M Buy
2,217,216
+125,000
+6% +$1.86M 13.66% 3
2021
Q1 		$40M Hold
2,092,216
– – 19.52% 1
2020
Q4 		$12.9M Buy
+2,092,216
New +$6.69M 7.58% 5

Other funds holding AMRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM

Blue Water Life Science Advisors's AMRS Position: Q3 2021 in Review

Blue Water Life Science Advisors sold out of Amyris Inc. (AMRS) in Q3 2021, closing a stake of 2,217,216 shares — an estimated $36.3M sold.

Blue Water Life Science Advisors first reported a position in AMRS in Q4 2020 and held it in 3 quarters. The position peaked at $40M in Q1 2021. 208 funds tracked by Wall St. Rank hold AMRS as of Q3 2021.

  • Blue Water Life Science Advisors reported no remaining Amyris Inc. position as of Q3 2021 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 2,217,216 Amyris Inc. shares in Q3 2021, an estimated $36.3M.
  • Blue Water Life Science Advisors first reported a position in Amyris Inc. in Q4 2020 and held it in 3 quarters.
  • Blue Water Life Science Advisors's Amyris Inc. position peaked at $40M in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2021.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.